Carna Biosciences, Inc. (TYO:4572)

Revenue by Segment

Financials in millions JPY. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Drug Discovery Support Business	579.06M	636.24M	918.24M	1.10B	889.53M
Drug Discovery Support Business Growth	-8.99%	-30.71%	-16.58%	23.74%	-17.66%
Drug Discovery Business	-	-	707.65M	286.05M	1.13B
Drug Discovery Business Growth	-	-	147.39%	-74.64%	2027.30%
Total	579.06M	636.24M	1.63B	1.39B	2.02B
Total Growth	-8.99%	-60.87%	17.24%	-31.27%	78.02%

Revenue by Geography

Financials in millions JPY. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Japan	169.19M	198.82M	223.31M	218.75M	205.06M
Japan Growth	-14.90%	-10.96%	2.08%	6.67%	-26.23%
China	96.55M	92.47M	128.72M	202.92M	71.77M
China Growth	4.41%	-28.16%	-36.57%	182.74%	-37.30%
United States of America	259.61M	276.86M	-	-	-
United States of America Growth	-6.23%	-	-	-	-
Others	5.99M	6.80M	26.33M	37.88M	17.89M
Others Growth	-11.83%	-74.19%	-30.48%	111.69%	51.43%
Europe	47.71M	61.29M	112.95M	72.02M	80.97M
Europe Growth	-22.16%	-45.74%	56.84%	-11.05%	14.27%
North America	-	-	1.13B	855.19M	1.64B
North America Growth	-	-	32.67%	-47.91%	149.43%
Total	579.06M	636.23M	1.63B	1.39B	2.02B
Total Growth	-8.99%	-60.87%	17.24%	-31.27%	78.02%

Source: S&P Global Market Intelligence.